Hong Kong Training Portal on
Infection Control and Infectious Disease

Epidemiology

• Epidemiological and Clinical Features of Meningococcal Meningitis in Infants — China, 2006–2023
• Global Control of Meningococcal Disease (May 24, 2023)
• Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020 (April 2023)
• Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis (June 10, 2022)
• Risk Factors for Contracting Invasive Meningococcal Disease and Related Mortality: A Systematic Literature Review and Meta-analysis (April 05, 2022)
• Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data (May 24, 2021)
• Risk of antibiotic resistant meningococcal infections in Hajj pilgrims (August 23, 2019)
• Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010–2015 (April 24, 2018)
• Sex Difference in Meningococcal Disease Mortality, New York City, 2008-2016 (March 02, 2018)
• Invasive Meningococcal Disease on the Workplaces: a systematic review (October 23, 2017)

Clinical Management

• Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management—summary of updated NICE guidance (November 27, 2024)
• National Institute for Health and Care Excellence (NICE): Evidence review for investigating and diagnosing suspected meningococcal disease with blood and urine investigations (March 2024)
• UK guidelines and testing for invasive meningococcal disease (April 2021)
• Meningococcal disease, a clinical and epidemiological review (October 28, 2017)
• Pre-admission antibiotics for suspected cases of meningococcal disease (June 14, 2017)

Public Health Management

• Public health management of invasive meningococcal disease outbreaks: worldwide 1973–2018, a systematic review (August 20, 2024)
• Prevention and control of meningococcal disease: Updates from the Global Meningococcal Initiative in Eastern Europe (December 04, 2019)
• Mass chemoprophylaxis for control of outbreaks of meningococcal disease (August 22, 2018)
• Meningococcal disease and control in China: Findings and updates from the Global Meningococcal Initiative (GMI) (February 01, 2018)

Microbiology

• Cefotaxime-Resistant Neisseria meningitidis Sequence Type 4821 Causing Fulminant Meningitis (March 2025)
• Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis (November 08, 2019)

Vaccination

• Joint consensus on reducing the burden of invasive meningococcal disease in the Asia-Pacific region (March 19, 2025)

• Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial (December 05, 2024)
• Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young Adults (November 06, 2024)
• Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context (May 31, 2024)
• Impact of Meningococcal B Vaccine on Invasive Meningococcal Disease in Adolescents (February 15, 2021)
• Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal (December 01, 2020)
• Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020 (September 25, 2020)
• Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England (January 22, 2020)
• Meningococcal vaccines in Australia: a 2019 update (August 01, 2019) 
• A Review of Meningococcal Disease and Vaccination Recommendations for Travelers (March 17, 2018)
• High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine (July 14, 2017)
• Effectiveness and duration of protection of one dose of a meningococcal conjugate vaccine (February 01, 2017)